These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


814 related items for PubMed ID: 17656479

  • 1. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [Abstract] [Full Text] [Related]

  • 2. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, MMKD Study Group.
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.
    Boes E, Fliser D, Ritz E, König P, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Kronenberg F.
    J Am Soc Nephrol; 2006 Feb; 17(2):528-36. PubMed ID: 16382017
    [Abstract] [Full Text] [Related]

  • 4. Regulation of fibroblast growth factor-23 in chronic kidney disease.
    Westerberg PA, Linde T, Wikström B, Ljunggren O, Stridsberg M, Larsson TE.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI, Maestro ML, Pérez-Flores I, Valero R, Rafael S, Veganzones S, Calvo N, De la Orden V, De la Flor JC, Valga F, Vidaurreta M, Fernández-Pérez C, Barrientos A.
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.
    Morena M, Dupuy AM, Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux AS, Delcourt C, Canaud B, Cristol JP.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3389-97. PubMed ID: 19574342
    [Abstract] [Full Text] [Related]

  • 16. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 17. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.
    Bacchetta J, Dubourg L, Harambat J, Ranchin B, Abou-Jaoude P, Arnaud S, Carlier MC, Richard M, Cochat P.
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1741-8. PubMed ID: 20157196
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1989-1998. PubMed ID: 27561289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.